Reaction Details Report a problem with these data
Target
Mu-type opioid receptor
Ligand
BDBM457076
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
37.0±n/a nM
Citation
 Ratcliffe, P; Konetzki, I; Sitnikov, N; Koch, T; Jostock, R 1,3-diaza-spiro-[3.4]-octane derivatives US Patent  US10738015 Publication Date 8/11/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM457076
Synonyms:
Cis-3-[5-(cyclopropylmethyl)- 2-(dimethylamino)-6-oxo-2- phenyl-5,7- diazaspiro[3.4]octan-7- yl]propanenitrile | US10738015, Example SC-45
Type:
Small organic molecule
Emp. Form.:
C21H28N4O
Mol. Mass.:
352.4732
SMILES:
CN(C)[C@]1(C[C@@]2(C1)CN(CCC#N)C(=O)N2CC1CC1)c1ccccc1 |r,wU:3.2,wD:5.4,(3.8,3.97,;4.2,2.48,;5.68,2.08,;3.11,1.39,;2.02,.3,;.93,1.39,;2.02,2.48,;.03,2.64,;-1.44,2.16,;-2.77,2.93,;-4.11,2.16,;-5.44,2.93,;-6.77,3.7,;-1.44,.62,;-2.69,-.28,;.03,.15,;.5,-1.32,;-.53,-2.46,;-1.99,-2.94,;-.85,-3.97,;4.2,.3,;3.8,-1.18,;4.89,-2.27,;6.38,-1.87,;6.77,-.39,;5.68,.7,)|
Structure:
Search PDB for entries with ligand similarity: